VERA THERAPEUTICS INC
21,01
19-мая-25 15:00:02
15 мин. задержка
Акции
-0,24
-1,13%
Сегодняшний диапазон
20,64 - 21,50
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
09 май 2025 15:05:00 Источник Nasdaq GlobeNewswire
-
Vera Therapeutics Provides Business Update and Reports First Quarter 2025 Financial Results
06 май 2025 07:00:01 Источник Nasdaq GlobeNewswire
-
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
09 апр 2025 15:05:00 Источник Nasdaq GlobeNewswire
-
Vera Therapeutics Completes Full Enrollment in Pivotal ORIGIN Phase 3 Trial for Atacicept in IgAN
03 апр 2025 07:00:01 Источник Nasdaq GlobeNewswire
-
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11 мар 2025 15:28:05 Источник Nasdaq GlobeNewswire
-
Vera Therapeutics to Participate in the TD Cowen 45th Annual Health Care Conference
27 фев 2025 07:00:00 Источник Nasdaq GlobeNewswire
-
26 фев 2025 07:25:00 Источник Nasdaq GlobeNewswire
-
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
13 фев 2025 15:05:00 Источник Nasdaq GlobeNewswire
-
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
14 янв 2025 15:05:00 Источник Nasdaq GlobeNewswire
-
Vera Therapeutics Acquires Global Rights to Novel, Next Generation Dual BAFF/APRIL Inhibitor
13 янв 2025 06:00:00 Источник Nasdaq GlobeNewswire
-
Vera Therapeutics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
07 янв 2025 15:05:00 Источник Nasdaq GlobeNewswire
-
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
09 дек 2024 17:29:08 Источник Nasdaq GlobeNewswire
-
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
22 ноя 2024 15:05:00 Источник Nasdaq GlobeNewswire
-
Vera Therapeutics Appoints Jason S. Carter as Chief Legal Officer
18 ноя 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11 ноя 2024 15:05:00 Источник Nasdaq GlobeNewswire
-
11 ноя 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
Vera Therapeutics to Participate at Upcoming Investor Conferences
08 ноя 2024 15:05:00 Источник Nasdaq GlobeNewswire
-
Vera Therapeutics to Participate at Upcoming Investor Conferences
08 ноя 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
Vera Therapeutics Provides Business Update and Reports Third Quarter 2024 Financial Results
07 ноя 2024 07:00:01 Источник Nasdaq GlobeNewswire
-
Vera Therapeutics Announces Pricing of Public Offering of Class A Common Stock
29 окт 2024 19:22:02 Источник Nasdaq GlobeNewswire
- <<
- <
- 1
- >